1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Mobius Life Sciences

Have updates for this profile?  Please contribute data

Overview Known Decision Makers
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Type

Private Equity Firm

Location

Nottingham UK

Alternative Asset Classes

PE

Established

2009

Firm Ownership

Captive Arm – Corporate

Investment Team Staff

Total Staff

10
Mobius Life Sciences, a subsidiary of BioCity Nottingham Ltd, is a firm that provides seed-stage equity investment into early-stage bioscience, pharmaceutical, medical technology, and healthcare businesses based in the East Midlands of the UK. The firm's fund is generated by BioCity and Nottingham City Council.
Asset Class No. of Funds Currently Managed Funds Raised in Last 10 Years Est. Dry Powder Strategies
Private Equity - Early Stage, Early Stage: Seed, Early Stage: Start-up, Expansion / Late Stage, Spin-Offs
Real Estate - -
Private Debt - -
Infrastructure - -
Natural Resources - -
Asset Class No. of Funds Currently Managed AuM Date of AuM Strategies
Hedge Funds 0 -

Want to see more?

Request a demo for full access to this profile.

1 Known Decision Makers

Contact Name Position Location Email Telephone Asset Class
Chairman,BioCity Investments Ltd Nottingham, UK VC

Showing 1 of 1 known decision makers at Mobius Life Sciences

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a Demo to see more

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo